Myomo (MYO) EBT Margin Growth (3y) (2019 - 2025)
Powered by 
Analysis
Myomo (MYO) EBT Margin Growth (3y) (2019 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -429.00 |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 803.00 |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 260.00 |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 574.00 |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 764.00 |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 835.00 |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -1,045.00 |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 598.00 |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 423.00 |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 3,577.00 |
| Jun 30, 2025 | 3,282.00 |
| Mar 31, 2025 | 3,695.00 |
| Dec 31, 2024 | 6,269.00 |
| Sep 30, 2024 | 3,683.00 |
| Jun 30, 2024 | 7,054.00 |
| Mar 31, 2024 | 2,554.00 |
| Dec 31, 2023 | -2,059.00 |
| Sep 30, 2023 | 10,502.00 |
| Jun 30, 2023 | 36,562.00 |
| Mar 31, 2023 | 30,158.00 |
| Dec 31, 2022 | 10,409.00 |
| Sep 30, 2022 | 38,890.00 |
| Jun 30, 2022 | 21,212.00 |
| Mar 31, 2022 | 24,219.00 |
| Dec 31, 2021 | 27,013.00 |
| Sep 30, 2021 | 39,091.00 |
| Jun 30, 2021 | 33,231.00 |
| Mar 31, 2021 | 62,828.00 |
| Dec 31, 2020 | 28,712.00 |